En application du plan Vigipirate l'accès à l'Institut Pasteur est subordonné à la présentation d'une pièce d'identité
|XXII International Round Table on Nucleosides, Nucleotides and Nucleic Acids|
|The congress is jointly organized by french researchers from Institut Pasteur, Université d’Orléans and Université Paris-Descartes, together with the International Society of Nucleosides, Nucleotides and Nucleic Acids (IS3NA, http://www.is3na.org).
The dedicated Local Organizers and the top-class Scientific Committee have set-up an exciting scientific program keeping in mind that analogues of nucleosides, nucleotides and oligonucleotides are finding increased applications in biotechnology, biology, and medicine. The XXII IRT will bring together chemists, molecular biologists, biochemists, biologists, medicinal chemists and others, interested in understanding all aspects of this field. The 2016 XXII IRT aims to put at the forefront the latest developments in innovation-driven nucleos(t)ide and oligonucleotide chemistry both in academia and industry, for dealing with the new challenges of our century. The program will feature keynote lectures on following area:
Approved-drugs: from bench to bedside
Anti-cancer, anti-infective and other biologically active nucleos(t)ides
Innovation-driven nucleos(t)ide chemistry
Nucleotide signaling molecules
Synthesis and structure of nucleic acids
Oligonucleotides for therapeutic applications and biotechnology
Biochemistry of nucleosides and nucleic acids
Our young(er) colleagues (Faculty, Post-doctoral fellows, PhD students) are especially welcome to showcase their research (poster and oral presentations) and ideas, and to take advantage of this unique networking opportunity. We also have planned a very rich social program in addition to the scientific program and we suggest that you spend a few extra days in order to really experience the true life and hospitality of Paris.
Institut Pasteur - CIS - From 18 juillet 2016 to 22 juillet 2016
Contact: Sylvie Pochet (firstname.lastname@example.org)